Human Clinical Trial to Evaluate the Decolonization Efficacy of BM111 Against Carbapenem-Resistant Enterobacteriaceae (CRE) and Vancomycin-Resistant Enterococcus (VRE)
Clinical trial NCT07525089 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07525089
- Sponsor
- BioMe Inc.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-23
- Primary completion
- 2026-10-30
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.